Top hedge funds flock to Allergan amid Ackman-backed Valeant bid: Reuters
Investor William Ackman has been joined by several top hedge funds, including Paulson & Co, York Capital Management and Viking Global Investors, that have made bets on takeover target Allergan Inc, Reuters reported. New regulatory filings give the first look at Allergan's redrawn shareholder map since Ackman and deal partner, Laval, Québec-based Valeant Pharmaceuticals Inc, made public their US$49 billion pursuit of the Botox maker in late April.
15 August 2014•3 mins read
